Entrada Therapeutics, Inc. Uncategorized Contracts & Agreements
4 Contracts & Agreements
- Amendment to Sublicense Agreement, dated October 26, 2023, by and between Entrada Therapeutics, Inc. and Vertex Pharmaceuticals Incorporated (Filed With SEC on November 1, 2023)
- Sublicense Agreement dated December 7, 2022, by and between the Registrant and Vertex Pharmaceuticals Incorporated (Filed With SEC on May 10, 2023)
- Sublicense Agreement dated December 7, 2022, by and between the Registrant and Vertex Pharmaceuticals Incorporated (Filed With SEC on March 6, 2023)
- Description of Securities of the Registrant (Filed With SEC on March 15, 2022)
